Back
Reviva Pharmaceuticals Holdings Vs. NovaBay Pharmaceuticals Industry Stock Comparison
Buy
59
RVPH
Reviva Pharmaceuticals Holdings
Last Price:
1.32
Seasonality Move:
6.98%
Sell
25
NBY
NovaBay Pharmaceuticals
Last Price:
0.50
Seasonality Move:
-14.79%
Buy
59
Reviva Pharmaceuticals Holdings (RVPH)
is a Buy
Is Reviva Pharmaceuticals Holdings a Buy, Sell or Hold?
- The current Reviva Pharmaceuticals Holdings [RVPH] share price is $1.31. The Score for RVPH is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
- RVPH is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
25
NovaBay Pharmaceuticals (NBY)
is a Sell
Is NovaBay Pharmaceuticals a Buy, Sell or Hold?
- The current NovaBay Pharmaceuticals [NBY] share price is $0.50. The Score for NBY is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
- NBY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
RVPH Stock Price Chart
What is Reviva Pharmaceuticals Holdings's stock price today?
-
The Reviva Pharmaceuticals Holdings share price today is $1.31
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RVPH is experiencing selling pressure, which indicates risk of future bearish movement.
NBY Stock Price Chart
What is NovaBay Pharmaceuticals's stock price today?
-
The NovaBay Pharmaceuticals share price today is $0.50
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBY is experiencing slight selling pressure.
RVPH Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.08 | Buy |
Relative Strength Index (14 RSI): | 57.89 | Buy |
Chaikin Money Flow: | -226670 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.9 - 1.32) | Buy |
Bollinger Bands (100): | (0.83 - 1.93) | Sell |
NBY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.09 | Sell |
Relative Strength Index (14 RSI): | 37.14 | Sell |
Chaikin Money Flow: | -28552 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.47 - 0.53) | Sell |
Bollinger Bands (100): | (0.58 - 3.38) | Sell |
RVPH Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.26 | Buy |
20-day SMA: | 1.18 | Buy |
50-day SMA: | 1.07 | Buy |
200-day SMA: | 2.63 | Sell |
8-day EMA: | 1.27 | Buy |
20-day EMA: | 1.19 | Buy |
50-day EMA: | 1.2 | Buy |
200-day EMA: | 2.32 | Sell |
NBY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.49 | Buy |
20-day SMA: | 0.49 | Buy |
50-day SMA: | 0.86 | Sell |
200-day SMA: | 3.79 | Sell |
8-day EMA: | 0.49 | Buy |
20-day EMA: | 0.53 | Sell |
50-day EMA: | 0.95 | Sell |
200-day EMA: | 8.34 | Sell |
Reviva Pharmaceuticals Holdings Earnings Growth & RVPH Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.17 per share, a decrease next quarter of $0.03 per share, an increase this year of $0.71 per share, and a decrease next year of $0.04 per share.
NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates
- Analysts estimate an earnings increase this quarter of $13.87 per share, an increase next quarter of $0.05 per share, an increase this year of $78.20 per share, and an increase next year of $1.81 per share.
Reviva Pharmaceuticals Holdings Technical Analysis
Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
NovaBay Pharmaceuticals Technical Analysis
Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |